CRBP logo

CRBP
Corbus Pharmaceuticals Holdings Inc

21,437
Mkt Cap
$170.8M
Volume
192,527.00
52W High
$20.56
52W Low
$4.64
PE Ratio
-1.61
CRBP Fundamentals
Price
$9.05
Prev Close
$9.63
Open
$9.53
50D MA
$8.36
Beta
1.19
Avg. Volume
160,039.73
EPS (Annual)
-$5.90
P/B
1.15
Rev/Employee
$0.00
$53.90
Loading...
Loading...
News
all
press releases
HC Wainwright Issues Negative Forecast for CRBP Earnings
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - Research analysts at HC Wainwright dropped their Q1 2026 earnings estimates for shares of Corbus Pharmaceuticals in a research...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
How Much Upside is Left in Corbus Pharmaceuticals (CRBP)? Wall Street Analysts Think 318.33%
The mean of analysts' price targets for Corbus Pharmaceuticals (CRBP) points to a 318.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·7d ago
News Placeholder
Research Analysts Offer Predictions for CRBP FY2030 Earnings
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - Equities researchers at HC Wainwright issued their FY2030 earnings per share (EPS) estimates for shares of Corbus Pharmaceuticals...
MarketBeat·7d ago
News Placeholder
Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Expected to Rise, Oppenheimer Analyst Says
Oppenheimer boosted their price target on shares of Corbus Pharmaceuticals from $53.00 to $57.00 and gave the company an "outperform" rating in a research report on Tuesday...
MarketBeat·8d ago
News Placeholder
Corbus Pharmaceuticals (NASDAQ:CRBP) Releases Quarterly Earnings Results
Corbus Pharmaceuticals (NASDAQ:CRBP - Get Free Report) announced its quarterly earnings results on Monday. The biopharmaceutical company reported ($1.25) earnings per share for the quarter, beating...
MarketBeat·9d ago
News Placeholder
Corbus Pharmaceuticals (CRBP) to Release Quarterly Earnings on Tuesday
Corbus Pharmaceuticals (NASDAQ:CRBP) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...
MarketBeat·16d ago
News Placeholder
Corbus Pharmaceuticals Touts Catalyst-Rich 2026 With CRB-701 and CRB-913 Data Readouts Ahead
Corbus Pharmaceuticals (NASDAQ:CRBP) outlined a catalyst-rich 2026 at Oppenheimer's 36th Annual Healthcare Conference, with Chief Executive Officer Yuval Cohen highlighting upcoming mid-year and...
MarketBeat·21d ago
News Placeholder
Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Rating Upgraded by Jefferies Financial Group
Jefferies Financial Group raised Corbus Pharmaceuticals to a "strong-buy" rating in a research note on Wednesday...
MarketBeat·27d ago
News Placeholder
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eleven research firms that are currently covering the firm...
MarketBeat·30d ago
News Placeholder
Corbus Pharmaceuticals (NASDAQ:CRBP) COO Ian Hodgson Sells 2,415 Shares
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) COO Ian Hodgson sold 2,415 shares of the business's stock in a transaction that occurred on Tuesday, February 3rd. The stock was...
MarketBeat·1mo ago
<
1
2
...
>

Latest CRBP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.